1. A patient with a mediastinal mass and diffuse asymptomatic osteolytic lesions. (10th January 2019) Authors: Hickmann, Sheila; Busato, Vanessa Barrili; Gomes da Silveira, Romulo; Guilherme Schaefer, Pedro; Bredemeier, Markus Journal: Rheumatology Issue: Volume 58:Number 7(2019) Page Start: 1314 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A patient with a mediastinal mass and diffuse asymptomatic osteolytic lesions. (1st April 2019) Authors: Hickmann, Sheila; Busato, Vanessa Barrili; Gomes da Silveira, Romulo; Guilherme Schaefer, Pedro; Bredemeier, Markus Journal: Rheumatology Issue: Volume 58:Number 7(2019) Page Start: 1317 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB1198 EVALUATION OF THE WAITING TIME AND QUALITY OF RHEUMATOLOGY REFERRAL AT A TERTIARY CARE CENTER OF PORTO ALEGRE – RS, BRAZIL. (June 2019) Authors: Busato, Vanessa; Piovesan, Deise; Silveira, Romulo; Hickmann, Sheila; Bongiorno, Guilherme; Cruz, Camila; Zamboni, Sheron; Simon, Julio; Bredemeier, Markus Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 2060 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Absence of Association of Joint Tenderness and High-Resolution Ultrasound Findings in Established Rheumatoid Arthritis. Issue 8 (December 2016) Authors: Defaveri do Prado, Aline; Bisi, Melissa C.; Piovesan, Deise Marcela; Bredemeier, Markus; Guimarães da Silveira, Inês; Mendonça, José Alexandre; Staub, Henrique Luiz Journal: Journal of clinical rheumatology Issue: Volume 22:Issue 8(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Additional points to consider before incorporating the Food and Drug Administration–approved therapies for systemic sclerosis–associated interstitial lung disease: comment on the article by Khanna et al. Issue 4 (21st February 2022) Authors: Bredemeier, Markus Journal: Arthritis & rheumatology Issue: Volume 74:Issue 4(2022) Page Start: 733 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Clinical and Methodologic Considerations With Regard to a Trial of Nintedanib in Patients With Systemic Sclerosis‐Associated Interstitial Lung Disease: Comment on the Reanalysis by Maher et al. Issue 12 (20th October 2021) Authors: Bredemeier, Markus Journal: Arthritis & rheumatology Issue: Volume 73:Issue 12(2021) Page Start: 2353 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Correspondence on 'Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trial'. Issue 12 (6th October 2020) Authors: Bredemeier, Markus Journal: Annals of the rheumatic diseases Issue: Volume 81:Issue 12(2022) Page Start: e250 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. EBV-positive mucocutaneous ulcer in a patient with systemic lupus erythematosus. (8th September 2019) Authors: Ritter, Clarice Gabardo; de David Cruz, Camila; Zamboni, Sheron; Busato, Vanessa Barrili; da Silveira, Romulo Gomes; Provenzi, Valentina Oliveira; Bredemeier, Markus Journal: Rheumatology Issue: Volume 59:Number 4(2020) Page Start: 916 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Evaluation of cytokines, oxidative stress markers and brain-derived neurotrophic factor in patients with fibromyalgia – A controlled cross-sectional study. (August 2016) Authors: Ranzolin, Aline; Duarte, Angela Luzia Branco Pinto; Bredemeier, Markus; da Costa Neto, Cláudio Antônio; Ascoli, Bruna Maria; Wollenhaupt-Aguiar, Bianca; Kapczinski, Flávio; Xavier, Ricardo Machado Journal: Cytokine Issue: Volume 84(2016) Page Start: 25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. FRI0142 SAFETY OF THE METHOTREXATE-LEFLUNOMIDE COMBINATION IN THE BRAZILIAN REGISTRY OF BIOLOGICAL THERAPIES IN RHEUMATIC DISEASES (BIOBADABRASIL). (June 2019) Authors: Bredemeier, Markus; Pinheiro, M; Macieira, C; Duarte, A; Stadler, B; Ranza, R; Medeiros, Ana; Valim, V; Bertolo, M; Miranda, J; Brenol, C; Castro, G; Fernandes, V; Titton, D; Sauma, F; Pereira, I; Botelho, R; Carvalho, H; Hayata, A; Louzada, P Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 741 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗